Catalent, Inc (CTLT) – Collaborations to leverage growth

CTLT also announced its entry into cell and gene therapy via the acquisition of Delphi Genetics. The company also launched plasmid DNA development manufacturing services through an organic investment in Rockville, Maryland facility.

Highlights 

Valuation

– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– P/E Analysis
– Peer Valuation.
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

No of Pages : 32